WO2006129056A3 - Process and novel salt - Google Patents

Process and novel salt Download PDF

Info

Publication number
WO2006129056A3
WO2006129056A3 PCT/GB2006/001830 GB2006001830W WO2006129056A3 WO 2006129056 A3 WO2006129056 A3 WO 2006129056A3 GB 2006001830 W GB2006001830 W GB 2006001830W WO 2006129056 A3 WO2006129056 A3 WO 2006129056A3
Authority
WO
WIPO (PCT)
Prior art keywords
novel salt
novel
salts
compositions
novels
Prior art date
Application number
PCT/GB2006/001830
Other languages
French (fr)
Other versions
WO2006129056A2 (en
Inventor
Kreso Mihaljevic
Blazenko Bajic
Drazen Cavuzic
Ruzica Oreskovic
Original Assignee
Pliva Hrvatska D O O
Mcleish Nicholas Alistair Maxw
Kreso Mihaljevic
Blazenko Bajic
Drazen Cavuzic
Ruzica Oreskovic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0511000A external-priority patent/GB0511000D0/en
Priority claimed from GB0515775A external-priority patent/GB0515775D0/en
Application filed by Pliva Hrvatska D O O, Mcleish Nicholas Alistair Maxw, Kreso Mihaljevic, Blazenko Bajic, Drazen Cavuzic, Ruzica Oreskovic filed Critical Pliva Hrvatska D O O
Priority to EP06727135A priority Critical patent/EP1888606A2/en
Publication of WO2006129056A2 publication Critical patent/WO2006129056A2/en
Publication of WO2006129056A3 publication Critical patent/WO2006129056A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a process of preparing risedronic acid, or a pharmaceutically acceptable salt thereof, novel risedronate ammonium salts and pharmaceutical compositions thereof, and the use of such novels salts and compositions in human therapy.
PCT/GB2006/001830 2005-05-28 2006-05-18 Process and novel salt WO2006129056A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06727135A EP1888606A2 (en) 2005-05-28 2006-05-18 Process and novel salt

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0511000.2 2005-05-28
GB0511000A GB0511000D0 (en) 2005-05-28 2005-05-28 Novel salt
GB0515775.5 2005-07-30
GB0515775A GB0515775D0 (en) 2005-07-30 2005-07-30 Process

Publications (2)

Publication Number Publication Date
WO2006129056A2 WO2006129056A2 (en) 2006-12-07
WO2006129056A3 true WO2006129056A3 (en) 2007-03-29

Family

ID=36932950

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2006/001830 WO2006129056A2 (en) 2005-05-28 2006-05-18 Process and novel salt

Country Status (2)

Country Link
EP (1) EP1888606A2 (en)
WO (1) WO2006129056A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8076483B2 (en) 2006-05-11 2011-12-13 M/S. Ind Swift Laboratories Limited Process for the preparation of pure risedronic acid or salts
KR100775440B1 (en) * 2006-12-20 2007-11-12 동우신테크 주식회사 Process for preparing sodium risedronate hemipentahydrate
WO2011023280A1 (en) * 2009-08-28 2011-03-03 Synthon B.V. Process for making 1-hydroxyalkylidene-1,1-biphosphonic acids

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT47948A (en) * 1986-09-17 1989-04-28 Mta Koezponti Kemiai Kutato In Process for producing poly-(hydroxyphosphonic acids) and their derivatives
WO2001057052A1 (en) * 2000-02-01 2001-08-09 The Procter & Gamble Company Process for making geminal bisphosphonates
EP1243592A2 (en) * 2001-03-19 2002-09-25 Adamed SP. Z O.O. A process for the preparation of risedronic acid
WO2003086355A1 (en) * 2002-04-11 2003-10-23 Teva Pharmaceutical Indudstries, Ltd. Novel polymorphs and pseudopolymorphs of risedronate sodium
US6638920B2 (en) * 2000-07-21 2003-10-28 Merck & Co., Inc. Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
US20040192655A1 (en) * 2003-01-17 2004-09-30 Revital Lifshitz-Liron Risedronate sodium having a very low content of iron
WO2005066190A1 (en) * 2004-01-02 2005-07-21 Hexal A/S New risedronate salts

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT47948A (en) * 1986-09-17 1989-04-28 Mta Koezponti Kemiai Kutato In Process for producing poly-(hydroxyphosphonic acids) and their derivatives
WO2001057052A1 (en) * 2000-02-01 2001-08-09 The Procter & Gamble Company Process for making geminal bisphosphonates
US6638920B2 (en) * 2000-07-21 2003-10-28 Merck & Co., Inc. Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
EP1243592A2 (en) * 2001-03-19 2002-09-25 Adamed SP. Z O.O. A process for the preparation of risedronic acid
WO2003086355A1 (en) * 2002-04-11 2003-10-23 Teva Pharmaceutical Indudstries, Ltd. Novel polymorphs and pseudopolymorphs of risedronate sodium
US20040192655A1 (en) * 2003-01-17 2004-09-30 Revital Lifshitz-Liron Risedronate sodium having a very low content of iron
WO2005066190A1 (en) * 2004-01-02 2005-07-21 Hexal A/S New risedronate salts

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Actonel", PACKAGE INSERT TEXT, 1 May 2002 (2002-05-01), XP002314021 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; TELEGDI, LASZLO, MRS. ET AL: "Producing poly(hydroxyphosphonic acids) and their derivatives as corrosion inhibitors", XP002398055, retrieved from STN Database accession no. 112:77536 *
STAHL KENNY ET AL: "Ammonium 1-hydroxy-2-(2-pyridinio)ethane-1,1-diyldiphosphonate dihydrate and potassium 1-hydroxy-2-(2-pyridinio)ethane-1,1-diyldipho sphonate dihydrate.", ACTA CRYSTALLOGRAPHICA. SECTION C, CRYSTAL STRUCTURE COMMUNICATIONS. MAR 2006, vol. 62, no. Pt 3, March 2006 (2006-03-01), pages m112 - m115, XP002398012, ISSN: 0108-2701 *

Also Published As

Publication number Publication date
EP1888606A2 (en) 2008-02-20
WO2006129056A2 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
WO2008002245A3 (en) Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3)
WO2008000483A3 (en) Phenol derivatives for the treatment of respiratory diseases
WO2009121872A3 (en) Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
UA107112C2 (en) Activator of soluble guanylate cyclase
WO2010065709A3 (en) Hydroxamic acid derivatives, preparation and therapeutic uses thereof
WO2009071480A3 (en) Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors
IL198314A (en) Quinuclidine derivatives of (hetero) arylcycloheptanecarboxylic acid, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for therapy
WO2008001195A3 (en) Novel processes for the preparation of dpp iv inhibitors
UA93709C2 (en) 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions
WO2010067078A3 (en) 3,6-disubstituted xanthylium salts as medicaments
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
UA83900C2 (en) Amorphous forms of risedronate monosodium
WO2009053628A3 (en) Novel compounds, preparation and uses thereof
WO2006129056A3 (en) Process and novel salt
WO2010033981A3 (en) 5-azaindole bisphosphonates
WO2010033980A3 (en) 4-azaindole bisphosphonates
TW200833708A (en) Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
WO2007044574A3 (en) Pharmaceutical compositions, methods of preparation thereof, and methods of treatment
TW200736220A (en) Pyridylsulfonamide derivatives, their manufacture and use as pharmaceutical agents
WO2007054139A3 (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
WO2007144889A3 (en) Treatment of neurofibromatosis
WO2007146375A3 (en) Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer
WO2007054725A3 (en) Combination of a cdk-inhibitor and a hdac-inhibitor
WO2007093608A8 (en) Drug combinations for the treatment of respiratory tract diseases

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006727135

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

WWP Wipo information: published in national office

Ref document number: 2006727135

Country of ref document: EP